|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.Japan |
First Approval Date07 Aug 1964 |
100 Clinical Results associated with Jerome Stevens Pharmaceuticals, Inc.
0 Patents (Medical) associated with Jerome Stevens Pharmaceuticals, Inc.
100 Deals associated with Jerome Stevens Pharmaceuticals, Inc.
100 Translational Medicine associated with Jerome Stevens Pharmaceuticals, Inc.